Immunovant, Inc. (IMVT)
32.11
-1.14
(-3.43%)
USD |
NASDAQ |
Oct 06, 16:00
32.12
+0.02
(+0.05%)
After-Hours: 20:00
Immunovant Price to Book Value : 9.006 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 9.006 |
| October 05, 2026 | 9.326 |
| October 02, 2026 | 9.430 |
| October 01, 2026 | 9.438 |
| September 30, 2026 | 9.475 |
| September 29, 2026 | 9.385 |
| September 28, 2026 | 9.393 |
| September 25, 2026 | 9.340 |
| September 24, 2026 | 9.536 |
| September 23, 2026 | 9.688 |
| September 22, 2026 | 10.46 |
| September 21, 2026 | 10.43 |
| September 18, 2026 | 10.36 |
| September 17, 2026 | 10.56 |
| September 16, 2026 | 10.20 |
| September 15, 2026 | 10.28 |
| September 14, 2026 | 10.56 |
| September 11, 2026 | 10.48 |
| September 10, 2026 | 10.69 |
| September 09, 2026 | 10.87 |
| September 08, 2026 | 11.10 |
| September 04, 2026 | 11.01 |
| September 03, 2026 | 10.97 |
| September 02, 2026 | 11.08 |
| September 01, 2026 | 11.19 |
| Date | Value |
|---|---|
| August 31, 2026 | 11.45 |
| August 28, 2026 | 11.56 |
| August 27, 2026 | 12.29 |
| August 26, 2026 | 12.31 |
| August 25, 2026 | 12.20 |
| August 24, 2026 | 12.15 |
| August 21, 2026 | 12.45 |
| August 20, 2026 | 12.44 |
| August 19, 2026 | 12.61 |
| August 18, 2026 | 12.43 |
| August 17, 2026 | 12.26 |
| August 14, 2026 | 11.73 |
| August 13, 2026 | 11.73 |
| August 12, 2026 | 11.95 |
| August 11, 2026 | 11.48 |
| August 10, 2026 | 11.19 |
| August 07, 2026 | 11.21 |
| August 06, 2026 | 11.15 |
| August 05, 2026 | 11.02 |
| August 04, 2026 | 11.04 |
| August 03, 2026 | 10.80 |
| July 31, 2026 | 10.83 |
| July 30, 2026 | 11.07 |
| July 29, 2026 | 10.83 |
| July 28, 2026 | 10.91 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Roivant Sciences Ltd. | 6.068 |
| Moderna, Inc. | 11.06 |
| Altimmune, Inc. | 1.095 |
| Vertex Pharmaceuticals, Inc. | 6.285 |
| First Tracks Biotherapeutics, Inc. | 6.581 |
Price to Book Value Related Metrics
| Price | 32.11 |
| Earnings Yield | -8.75% |
| Market Cap | 6.623B |